ES418113A1 - Piperazino-pyrimidines process for their preparation and use - Google Patents

Piperazino-pyrimidines process for their preparation and use

Info

Publication number
ES418113A1
ES418113A1 ES418113A ES418113A ES418113A1 ES 418113 A1 ES418113 A1 ES 418113A1 ES 418113 A ES418113 A ES 418113A ES 418113 A ES418113 A ES 418113A ES 418113 A1 ES418113 A1 ES 418113A1
Authority
ES
Spain
Prior art keywords
formula
pyrimidine
group
preparation
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES418113A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Produits Chimiques Ugine Kuhlmann
Ugine Kuhlmann SA
Original Assignee
Produits Chimiques Ugine Kuhlmann
Ugine Kuhlmann SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Produits Chimiques Ugine Kuhlmann, Ugine Kuhlmann SA filed Critical Produits Chimiques Ugine Kuhlmann
Publication of ES418113A1 publication Critical patent/ES418113A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

A procedure for the preparation of pyrimidine derivatives of the general formula: **(See formula)** where R represents a methyl or methylthio group, X represents a halogen atom or an alkoxy group of 1 to 5 carbon atoms, Y represents an optionally substituted acylamino or amino group, Z represents a hydrogen atom or a methyl, ethyl group, hydroxyethyl or phenyl, except for 2-methylamino-4-N-methylpiperazino-5-methylthio-6-chloro-pyrimidine, whose procedure is characterized by reacting a 4,6-dichloro-pyrimidine of formula: **(See formula)** with a piperazine of the formula: **(See formula)** in an anhydrous medium, in the presence of an acid accepting agent, at a temperature comprised between 40 and 120ºC and, if necessary, replace the chlorine atom of the product obtained with an alkoxy group. (Machine-translation by Google Translate, not legally binding)
ES418113A 1973-07-06 1973-08-22 Piperazino-pyrimidines process for their preparation and use Expired ES418113A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7324874A FR2257294B1 (en) 1973-07-06 1973-07-06

Publications (1)

Publication Number Publication Date
ES418113A1 true ES418113A1 (en) 1976-03-16

Family

ID=9122191

Family Applications (1)

Application Number Title Priority Date Filing Date
ES418113A Expired ES418113A1 (en) 1973-07-06 1973-08-22 Piperazino-pyrimidines process for their preparation and use

Country Status (10)

Country Link
JP (1) JPS5849548B2 (en)
BE (1) BE803803A (en)
CH (1) CH582171A5 (en)
DE (1) DE2342880A1 (en)
ES (1) ES418113A1 (en)
FR (1) FR2257294B1 (en)
GB (1) GB1434544A (en)
LU (1) LU68263A1 (en)
MX (1) MX2978E (en)
NO (1) NO137205C (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605319A (en) * 1975-05-23 1976-11-25 Mar Pha Etu Expl Marques PROCESS FOR PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND PROCESS FOR PREPARING SUITABLE MEDICINAL COMPOUNDS.
FR2417507A2 (en) * 1977-07-28 1979-09-14 Ugine Kuhlmann DIAMINO-2,4 (OR -4,6) METHYLTHIO-5 PYRIMIDINES HERBICIDES
JPS54159877A (en) * 1978-06-07 1979-12-18 Matsushita Electronics Corp Detection method for semiconductor substrate position and break
FR2503162A1 (en) * 1981-04-07 1982-10-08 Pharmindustrie NOVEL PIPERAZINO-2 PYRIMIDINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS OR AS INTERMEDIATES FOR THE PRODUCTION OF MEDICAMENTS
JPS6177335A (en) * 1984-09-25 1986-04-19 Kazumichi Kimura Defective mark detector for semiconductor pellet
IT1191845B (en) * 1986-01-20 1988-03-23 Dompe Farmaceutici Spa PHARMACOLOGICALLY ACTIVE ALCHYLOLS
JPH02114936U (en) * 1989-03-03 1990-09-14

Also Published As

Publication number Publication date
LU68263A1 (en) 1973-10-24
MX2978E (en) 1980-01-17
NO326073L (en) 1975-02-03
FR2257294B1 (en) 1977-07-01
DE2342880A1 (en) 1975-01-30
NO137205C (en) 1978-01-18
NO137205B (en) 1977-10-10
BE803803A (en) 1974-02-20
GB1434544A (en) 1976-05-05
JPS5025578A (en) 1975-03-18
CH582171A5 (en) 1976-11-30
FR2257294A1 (en) 1975-08-08
JPS5849548B2 (en) 1983-11-05

Similar Documents

Publication Publication Date Title
ES467288A1 (en) N-(substituted-aminoalkyl)-2-oxo-1-pyrrolidineacetamides
ES391299A1 (en) 2-(n-allyl-phenylamino)-imidazolines-(2)and salts thereof
ES417333A1 (en) Omega-(4'-(3"-indolyl)-piperidino)-alkyl-arylketones
ES418113A1 (en) Piperazino-pyrimidines process for their preparation and use
ES442845A2 (en) Novel derivatives of N-(3,4,5-trimethoxy cinnamoyl)piperazine and the process for preparing them
GB866843A (en) Sulphonamidopyrimidines
ES448721A1 (en) A procedure for the production of antibacterial amidic compounds. (Machine-translation by Google Translate, not legally binding)
ES440030A1 (en) 2-aminoindane derivatives
ES450380A1 (en) Indaneacetic acid derivatives
ES389360A1 (en) Aryloxy-and arylthioalkanoic acids and esters and salts thereof
ES423104A1 (en) Procedure for preparing heterociclic anilides. (Machine-translation by Google Translate, not legally binding)
ES436624A1 (en) Pyrimidones
ES440153A2 (en) Piperazinopyrimidines process for their preparation and use
ES437803A1 (en) Novel thiophene derivatives and their preparation
GB1451477A (en) Phenylamidinourea derivatives processes for their preparation and compositions incorporating them
ES435351A1 (en) 1-(3-phenylpropyl)-4-furoylpiperazine derivatives
ES419450A1 (en) Exchange amination process
ES389161A1 (en) Formamidine derivatives and the composition containing same
GB1501795A (en) Phenylsulphonyl formamidine derivatives and their preparation and use
ES425533A1 (en) Dichlorothiazolylureas processes for their preparation and their use as herbicides
ES401342A1 (en) Pyridine derivatives
ES301710A1 (en) Procedure for the preparation of new 1,2-diaril-4-alkyl-3,5-dioxo-pirazolidines (Machine-translation by Google Translate, not legally binding)
ES387840A1 (en) 2-(2-imidazolin-2-ylthio)-acetanilides
ES411445A1 (en) Procedure for the preparation of 4,6-dichloro-pirazolo- (3,4-d) -pirimidine or its derivatives. (Machine-translation by Google Translate, not legally binding)
GB877106A (en) Substituted urea complex salts